MRTX
Point72 Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-258,563
| Closed | -$11.3M | – | 2252 |
|
|
2023
Q3 | $11.3M | Buy |
+258,563
| New | +$11.3M | 0.03% | 533 |
|
|
2023
Q2 | – | Sell |
-645,500
| Closed | -$24M | – | 2299 |
|
|
2023
Q1 | $24M | Sell |
645,500
-108,100
| -14% | -$4.02M | 0.07% | 278 |
|
|
2022
Q4 | $34.1M | Buy |
753,600
+651,753
| +640% | +$29.5M | 0.12% | 216 |
|
|
2022
Q3 | $7.11M | Sell |
101,847
-8,753
| -8% | -$611K | 0.03% | 556 |
|
|
2022
Q2 | $7.43M | Buy |
+110,600
| New | +$7.43M | 0.03% | 527 |
|
|
2022
Q1 | – | Sell |
-479,845
| Closed | -$70.4M | – | 1345 |
|
|
2021
Q4 | $70.4M | Buy |
+479,845
| New | +$70.4M | 0.28% | 71 |
|
|
2021
Q3 | – | Sell |
-40,000
| Closed | -$6.46M | – | 1212 |
|
|
2021
Q2 | $6.46M | Sell |
40,000
-227,400
| -85% | -$36.7M | 0.03% | 513 |
|
|
2021
Q1 | $45.8M | Buy |
267,400
+51,937
| +24% | +$8.9M | 0.21% | 116 |
|
|
2020
Q4 | $47.3M | Buy |
+215,463
| New | +$47.3M | 0.23% | 100 |
|
|
2020
Q3 | – | Sell |
-186,721
| Closed | -$21.3M | – | 1079 |
|
|
2020
Q2 | $21.3M | Buy |
+186,721
| New | +$21.3M | 0.14% | 203 |
|
|
2019
Q4 | – | Sell |
-596,169
| Closed | -$46.4M | – | 1264 |
|
|
2019
Q3 | $46.4M | Buy |
596,169
+187,234
| +46% | +$14.6M | 0.29% | 100 |
|
|
2019
Q2 | $42.1M | Buy |
408,935
+391,735
| +2,278% | +$40.3M | 0.22% | 107 |
|
|
2019
Q1 | $1.26M | Buy |
+17,200
| New | +$1.26M | 0.01% | 679 |
|
|
2018
Q4 | – | Sell |
-15,500
| Closed | -$730K | – | 1128 |
|
|
2018
Q3 | $730K | Buy |
+15,500
| New | +$730K | ﹤0.01% | 733 |
|
|
2018
Q2 | – | Sell |
-407,929
| Closed | -$12.5M | – | 1047 |
|
|
2018
Q1 | $12.5M | Buy |
407,929
+327,030
| +404% | +$10M | 0.05% | 313 |
|
|
2017
Q4 | $1.48M | Buy |
+80,899
| New | +$1.48M | 0.01% | 632 |
|